Inventor · disambiguated record
Daniel W. Gil
Also filed as: GIL DANIEL · GIL DANIEL W · GIL DANIEL WALTER
90 granted patents·93 pending applications·1,161 citations·filing 1993–2025
99Inventor score
Top patents by PatentIndex Score
183 records- 0198US6787517B1Agent and methods for treating painALLERGAN INC·Filed 2000·Granted Sep 7, 2004·134 cites·46 claims
- 0297US7141597B2Nonsedating α-2 agonistsALLERGAN INC·Filed 2004·Granted Nov 28, 2006·76 cites·13 claims
- 0397US7091232B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2003·Granted Aug 15, 2006·112 cites·3 claims
- 0497US6534542B2(2-hydroxy)ethyl-thioureas useful as modulators of α2B adrenergic receptorsALLERGAN INC·Filed 2001·Granted Mar 18, 2003·82 cites·54 claims
- 0597US6329369B1Methods of treating pain and other conditionsALLERGAN SALES INC·Filed 2000·Granted Dec 11, 2001·83 cites·17 claims
- 0696US7345065B2Methods and compositions for alleviating painALLERGAN INC·Filed 2002·Granted Mar 18, 2008·74 cites·60 claims
- 0795US11077053B2Alpha-2-adrenergic receptor agonists for treatment of presbyopia, visual glare, visual starbursts, visual halos and night myopiaALLERGAN INC·Filed 2020·Granted Aug 3, 2021·4 cites·11 claims
- 0894US6841684B2Imidiazoles having reduced side effectsALLERGAN INC·Filed 2001·Granted Jan 11, 2005·72 cites·18 claims
- 0994US6294553B1Method for treating ocular painALLERGAN SALES INC·Filed 2001·Granted Sep 25, 2001·52 cites·11 claims
- 1092US7977335B2Methods of preventing and reducing the severity of stress-associated conditionsALLERGAN INC·Filed 2008·Granted Jul 12, 2011·14 cites·1 claims
- 1192US7323485B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2006·Granted Jan 29, 2008·7 cites·5 claims
- 1292US7276522B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones, 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2004·Granted Oct 2, 2007·44 cites·3 claims
- 1392US6545182B2Methods and compositions for modulating alpha adrenergic receptor activityALLERGAN SALES INC·Filed 2001·Granted Apr 8, 2003·79 cites·15 claims
- 1491US10596282B2Sterilization device utilizing low intensity UV-C radiation and ozoneHEPCO HOLDINGS LLC·Filed 2019·Granted Mar 24, 2020·9 cites·16 claims
- 1591US8696985B2Foot/footwear sterilization systemHEPCO MEDICAL LLC·Filed 2013·Granted Apr 15, 2014·21 cites·20 claims
- 1691US8617479B2Foot/footwear sterilization systemHEPCO MEDICAL LLC·Filed 2012·Granted Dec 31, 2013·24 cites·10 claims
- 1791US7335803B2Methods and compositions for modulating alpha adrenergic receptor activityALLERGAN INC·Filed 2001·Granted Feb 26, 2008·40 cites·3 claims
- 1890US9283217B2Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditionsALLERGAN INC·Filed 2013·Granted Mar 15, 2016·6 cites·4 claims
- 1990US7345077B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2005·Granted Mar 18, 2008·12 cites·20 claims
- 2090US6313172B1Methods and compositions for modulating alpha adrenergic receptor activityALLERGAN SALES INC·Filed 2000·Granted Nov 6, 2001·42 cites·10 claims
- 2189US7399868B24-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonistsALLERGAN INC·Filed 2005·Granted Jul 15, 2008·11 cites·7 claims
- 2289US2025375423A1Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole derivatives for treating retinal diseasesALLERGAN INC·Filed 2024·Application pending·0 cites
- 2389US2025228823A1Pharmaceutical compositions comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanolALLERGAN INC·Filed 2024·Application pending·0 cites
- 2488US11638836B2Sterilization device utilizing low intensity UV-C radiation and ozoneHEPCO HOLDINGS LLC·Filed 2020·Granted May 2, 2023·2 cites·16 claims
- 2588US10335505B2Sterilization device for incision and wound sites utilizing low intensity UV-C radiation and ozoneHEPCO HOLDINGS LLC·Filed 2017·Granted Jul 2, 2019·6 cites·18 claims
- 2688US8784731B2Foot/footwear sterilization systemHEPCO MEDICAL LLC·Filed 2014·Granted Jul 22, 2014·15 cites·20 claims
- 2788US7419994B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2- thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cyloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2006·Granted Sep 2, 2008·8 cites·16 claims
- 2886US7312238B2Nonsedating α-2 agonistsALLERGAN INC·Filed 2006·Granted Dec 25, 2007·5 cites·3 claims
- 2985US8853251B2Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseasesALLERGAN INC·Filed 2013·Granted Oct 7, 2014·4 cites·7 claims
- 3085US8492557B2Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanolCHOW KEN·Filed 2011·Granted Jul 23, 2013·5 cites·12 claims
- 3185US8492422B2Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditionsDIBAS MOHAMMAD I·Filed 2011·Granted Jul 23, 2013·5 cites·7 claims
- 3285US7358269B22-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronapthalen-1(2H)-oneALLERGAN INC·Filed 2006·Granted Apr 15, 2008·6 cites·6 claims
- 3384US8653123B2Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseasesDIBAS MOHAMMAD I·Filed 2011·Granted Feb 18, 2014·4 cites·7 claims
- 3484US8455548B2Method of treating sensorimotor disorders with alpha-2 adrenergic receptor agonistsLUHRS LAUREN M B·Filed 2008·Granted Jun 4, 2013·6 cites·2 claims
- 3584US8329918B2Selective alpha 2B/2C agonistsNGUYEN PHONG X·Filed 2010·Granted Dec 11, 2012·7 cites·2 claims
- 3684US7855226B2Treatment of inflammatory bowel diseaseALLERGAN INC·Filed 2005·Granted Dec 21, 2010·5 cites·6 claims
- 3783US9095576B2Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseasesALLERGAN INC·Filed 2012·Granted Aug 4, 2015·3 cites·1 claims
- 3883US8575207B2Method of activating regulatory T cells with alpha-2B adrenergic receptor agonistsGIL DANIEL W·Filed 2011·Granted Nov 5, 2013·5 cites·1 claims
- 3983US7396849B24-(Condensed cyclicmethyl)-imidazole-2-thiones acting as α2 adrenergic agonistsALLERGAN INC·Filed 2005·Granted Jul 8, 2008·5 cites·21 claims
- 4083US2024043518A1Heavy chain only antibodies to pdgfALLERGAN INC·Filed 2023·Application pending·0 cites
- 4183US2024358682A1Use of alpha-2-adrenergic receptor agonists for improving visionALLERGAN INC·Filed 2024·Application pending·0 cites
- 4282US11028163B2Heavy chain only antibodies to PDGFALLERGAN INC·Filed 2019·Granted Jun 8, 2021·1 cites·8 claims
- 4382US8071636B2Methods of treating alpha adrenergic mediated conditionsFANG WENKUI K·Filed 2009·Granted Dec 6, 2011·4 cites·17 claims
- 4482US7683089B14-(Phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonistsALLERGAN INC·Filed 2005·Granted Mar 23, 2010·4 cites·2 claims
- 4581US11046756B2Heavy chain only antibodies to ANG-2ALLERGAN INC·Filed 2019·Granted Jun 29, 2021·1 cites·14 claims
- 4681US7569584B24-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-2-thione as specific alpha2b agonist and methods of using the sameALLERGAN INC·Filed 2007·Granted Aug 4, 2009·4 cites·11 claims
- 4781US2022233505A1Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole derivatives for treating retinal diseasesALLERGAN INC·Filed 2022·Application pending·0 cites
- 4880US10555933B2Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseasesALLERGAN INC·Filed 2018·Granted Feb 11, 2020·1 cites·2 claims
- 4980US9555021B2Pharmaceutical compositions comprising (3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl)methanolALLERGAN INC·Filed 2015·Granted Jan 31, 2017·2 cites·19 claims
- 5080US2023062049A1Methods of treating alpha adrenergic mediated conditionsALLERGAN INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 183 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Daniel W. Gil files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →